Safety of bone marrow stem cell mobilization induced by granulocyte-colony stimulating factor: 30 Days' blinded clinical results from the Stem Cells in Myocardial Infarction (STEMMI) trial

HeartDrug

Volumn 5, Issue 4, 2005, Pages 177-182

  Ripa, Rasmus Sejersten ^a   Wang, Yongzhong ^a   Jørgensen, Erik ^a   Johnsen, Hans E ^b   Grande, Peer ^a   Kastrup, Jens ^a  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Angiogenesis; Coronary intervention, percutaneous; Granulocyte colony stimulating factor; ST elevation myocardial infarction; Stem cells

Indexed keywords

CREATINE KINASE ISOENZYME; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DEATH; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART REINFARCTION; HEART VENTRICLE ARRHYTHMIA; HEMATOPOIETIC STEM CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MITRAL VALVE REGURGITATION; MUSCULOSKELETAL PAIN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THROMBOSIS;

EID: 29144442367     PISSN: 14229528     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089596     Document Type: Article

References (22)

1. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161.
2. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221.
3. Yongzhong W, Johnsen HE, Jorgensen E, Kastrup J: The clinical impact of vascular growth factors and endothelial progenitor cells in the acute coronary syndrome. Scand Cardiovasc J 2003;37:18.
4. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004;44:1690.
5. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141.
6. Johnsen HE: Clinical practice and future needs in recombinant human granulocyte colony-stimulating factor treatment: a review of randomized trials in clinical haemato-oncology. J Int Med Res 2001;29:87.
7. Anderlini P, Donato M, Chan KW, Huh YO, Gee AP, Lauppe MJ, Champlin RE, Korbling M: Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: The M.D. Anderson Cancer Center experience. Transfusion 1999;39:555.
8. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001;98:10344.
9. Norol F, Merlet P, Isnard R, Sebillon P, Bonnet N, Cailliot C, Carrion C, Ribeiro M, Charlotte F, Pradeau P, Mayol JF, Peinnequin A, Drouet M, Safsafi K, Vernant JP, Herodin F: Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood 2003;102:4361.
10. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, Kim YJ, Soo LD, Sohn DW, Han KS, Oh BH, Lee MM, Park YB: Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751.
11. Hill JM, Paul JD, Powell TM, McCoy P, Dunbar CE, Horne M, Csako G, Cannon RO: Efficacy and risk of granulocyte colony stimulating factor administration in patients with severe, coronary artery disease. Circulation 2003;108(suppl IV):478.
12. Wang Y, Tägil K, Ripa RS, Nilsson JC, Carstensen S, Jorgensen E, Sondergaard L, Hesse B, Johnsen HE, Kastrup J: Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. Int J Cardiol 2005;100:477.
13. Libby P: Inflammation in atherosclerosis. Nature 2002;420:868.
14. Ikeda U: Inflammation and coronary artery disease. Curr Vasc Pharmacol 2003;1:65.
15. Matsubara H: Risk to the coronary arteries of intracoronary stem cell infusion and G-CSF cytokine therapy. Lancet 2004;363:746.
16. Kovacic JC, Graham RM: Stem-cell therapy for myocardial diseases. Lancet 2004;363:1735.
17. Pertzsch M, Ince H, Kleine HS, Schmidt H, Rehders T, Körber T, Freund M, Nienaber CA: No restenosis after G-CSF in acute myocardial infarction: insights from FIRSTLINE-AMI (front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor). Circulation 2004;110(suppl III):238.
18. Franz WM, Theiss HD, Hennig C, Wintersperger BJ, Huber A, Schoenberg SO, Engelmann MG: Bone marrow stem-cell mobilization induced by granulocyte-colony stimulating factor (G-CSF) in patients undergoing delayed revascularization for ST-segment elevation myocardial infarction. Circulation 2004;110(suppl III):324.
19. Valgimigli M, Rigolin GM, Cittanti C, Malagutti P, Curello S, Percoco G, Bugli AM, Porta MD, Bragotti LZ, Ansani L, Mauro E, Lanfranchi A, Giganti M, Feggi L, Castoldi G, Ferrari R: Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur Heart J 2005;26:1838-1845.
20. Ripa RS, Wang Y, Jørgensen E, Kastrup J: Bone-marrow stem cell mobilization induced by granulocyte-colony stimulating factor in patients with a PCI-treated acute ST-elevation myocardial infarction is safe: results from a double-blind randomized study, the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation 2004;110(suppl III):238.
21. Jørgensen E, Ripa RS, Helqvist S, Wang Y, Johnsen HE, Grande P, Kastrup J: In-stent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor. Preliminary intracoronary ultrasound results from a double-blind randomized placebo-controlled study of patients treated with percutaneous coronary intervention for ST-elevation myocardial infarction (STEMMI Trial). Int J Cardiol, in press.
22. Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J: Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 2004;43:18.